期刊文献+

阿维A对脓疱性银屑病患者外周血IL-8水平的影响

Effects of acitretin on the level of interleukin-8 (IL-8) in the peripheral blood of patients with pustular psoriasis
原文传递
导出
摘要 目的探讨脓疱性银屑病患者经阿维A治疗前后外周血中白介素8(IL-8)水平的变化。方法用双抗体夹心法(EuSA)检测患者治疗前、后外周血白介素(IL-8)的水平并与正常人进行比较,进一步评价IL-8与脓疱性银屑病病情的相关性。结果阿维A在改善脓疱性银屑病患者病情的同时,外周血IL-8的水平(治疗前96.84±14.68pg/ml,治疗后57.07±12.02pg/m1)显著下降,差异有统计学意义(P均〈0.05)。结论阿维A下调IL-8水平可能是其治疗脓疱性银屑病的作用机制之一。 Objective To investigate the changes of IL-8 in peripheral blood of patients with pustular psoriasis after aeitretin treatment. Methods Dual antibody sandwich enzyme-linked immunosorbent assay (ELISA) was performed to measure the IL-8 levels in the peripheral blood of 30 patients with pustular psoriasis and 30 patients with psoriasis vulgaris before and after treatment, and in 30 normal human controls. The relationship between the IL-8 level and disease severity was assessed for patients with pustular psoriasis. Results After acitretin treatment, the condition was improved greatly in patients with pustular psoriasis, together with a significant decrease in the level of IL-8 in the peripheral blood (57.07 ± 12.02 pg/ml vs. 96.84 ± 14.68 pg/ml, P 〈 0.05). Conclusion IL-8 may be involved in the therapeutic mechanism of acitretin in pustular psoriasis.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2011年第10期732-734,共3页 Chinese Journal of Dermatology
  • 相关文献

参考文献4

  • 1Lebwohl M. Psoriasis. Lancet, 2003, 361(9364): 1197-1204.
  • 2Gollnick HP. Oral retinoids--efficacy and toxicity in psoriasis. Br J Dermatol, 1996, 135 Suppl 49: 6-17.
  • 3Sjogren F, Ljunghusen O, Baas A, et al. Expression and function of beta 2 integrin CDllB/CD18 on leukocytes from patients with psoriasis. Acta Derm Venereol, 1999, 79(2): 105-110.
  • 4马敬,李玉平,李萍,闫华,冯世军,四荣联.银屑病患者皮损在阿维A治疗前后角蛋白10、14、17的变化[J].中华皮肤科杂志,2008,41(11):719-722. 被引量:1

二级参考文献6

  • 1Moll R, Franke WW, Schiller DL, et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell, 1982, 31( 1 ): 11-24.
  • 2Leigh IM, Navsaria H, Purkis PE, et al. Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Br J Dermatol, 1995, 133(4): 501-511.
  • 3de Jong EM, van Vlijmen IM, van Erp PE, et al. Keratin 17: a useful marker in anti-psoriatic therapies. Arch Dermatol Res, 1991, 283(7 ): 480-482.
  • 4Thewes M, Stadler R, Korge B, et al. Normal psoriatic epidermis expression of hyperproliferation-associated keratins. Arch Dermatol Res, 1991, 283(7): 465-471.
  • 5Holland DB, Wood E J, Cunliffe WJ, et al. Keratin gene expression during the resolution of psoriatic plaques: effect of dithranol, PUVA, etretinate and hydroxyurea regimens. Br J Dermatol, 1989, 120(1): 9-19.
  • 6陈玉欣,李巍,樊建勇,刘玉峰,高天文.反义寡核苷酸阻遏角蛋白14的表达[J].中华皮肤科杂志,2004,37(4):224-226. 被引量:2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部